835 results on '"Francis, Jasmine H."'
Search Results
2. Mucocutaneous Adverse Events in Patients With Cancer Treated with the Highly Selective RET Kinase Inhibitor Selpercatinib (LOXO-292)
3. Histiocytosis Advancements Parallel Ophthalmic Innovations: The LXXXI Edward Jackson Memorial Lecture
4. Plasma-Derived Cell-Free DNA for the Diagnosis of Ocular-Involving Histiocytosis
5. Ocular side effects of anticancer agents used in the treatment of gynecologic cancers
6. Improved method of dilating pupils for ophthalmic exams under anesthesia (faster and easier)
7. CSF1R inhibition for histiocytic neoplasm with CBL mutations refractory to MEK1/2 inhibition
8. Loss of polycomb repressive complex 1 activity and chromosomal instability drive uveal melanoma progression.
9. Subfoveal Choroidal Thickness in Patients with Histiocytosis and Multimodal Imaging Features of Choroidal Infiltrates
10. Ocular toxicities of fibroblast growth factor receptor inhibitors: A review
11. Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors
12. Validation of the Prognostic Usefulness of the Gene Expression Profiling Test in Patients with Uveal Melanoma
13. Second Primary Neoplasms in Retinoblastoma: Effect of Gene and Environment
14. A Unique Presentation of Bilateral Chorioretinal Atrophy
15. Advanced OCT Analysis of Biopsy-proven Vitreoretinal Lymphoma
16. Hearing Evaluations in Children With Retinoblastoma Treated With Intra-arterial Carboplatin Chemotherapy: A Single Institution Review.
17. Rosai–Dorfman–Destombes disease of the nervous system: a systematic literature review
18. Clinical and Morphologic Characteristics of Extracellular Signal-Regulated Kinase Inhibitor-Associated Retinopathy
19. Increased Risk of Skin Cancer in 1,851 Long-Term Retinoblastoma Survivors
20. RB1 Circulating Tumor DNA in the Blood of Patients with Unilateral Retinoblastoma: Before and after Intra-arterial Chemotherapy
21. EVALUATING LARGE LANGUAGE MODELS ON THEIR ACCURACY AND COMPLETENESS
22. Prognostic value of [18F]FDG PET/CT in patients with CNS lymphoma receiving ibrutinib-based therapies
23. Retrospective Evaluation of Somatic Alterations in Cell-Free DNA from Blood in Retinoblastoma
24. Intravitreal melphalan hydrochloride vs propylene glycol-free melphalan for retinoblastoma vitreous seeds: Efficacy, toxicity and stability in rabbits models and patients
25. Craniospinal irradiation and/or intraventricular radioimmunotherapy after high‐dose chemotherapy and autologous stem cell rescue in patients with CNS retinoblastoma—Safety and outcomes.
26. Ocular findings in patients with histiocytosis and association with clinical and molecular features.
27. Recommendations for Long-Term Follow-up of Adults with Heritable Retinoblastoma
28. Magnetic Resonance Imaging Screening for Trilateral Retinoblastoma: The Memorial Sloan Kettering Cancer Center Experience 2006–2016
29. Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy
30. A decision process for drug discovery in retinoblastoma
31. Intravitreous Cutaneous Metastatic Melanoma in the Era of Checkpoint Inhibition: Unmasking and Masquerading
32. Retinoblastoma
33. Refractive Shifts and Changes in Corneal Curvature Associated With Antibody–Drug Conjugates
34. Spectrum of Disease Severity and Phenotype in Choroideremia Carriers
35. Uveal melanoma metastatic at initial diagnosis: a case series
36. GNAQ Mutations in Diffuse and Solitary Choroidal Hemangiomas
37. Histiocytosis of the orbit and its association with KRASmutations
38. How Much Time Do Focal Treatments for Retinoblastoma Add to Anesthetic Exposure?
39. Circulating Tumor DNA Posttreatment Measurements and Clinical Correlates in Retinoblastoma
40. Clearance of plasma cell free DNA in metastatic uveal melanoma with radiographic response to immune checkpoint inhibitors
41. Non-RB1 germline cancer predisposing variants found in retinoblastoma patients
42. Second Primary Neoplasms in Retinoblastoma: Effect of Gene and Environment
43. Plasma Circulating Tumor DNA to Assist in the Diagnose of Unknown Primary Malignancy Underlying Choroidal Metastases
44. Current Treatment of Bilateral Retinoblastoma: The Impact of Intraarterial and Intravitreous Chemotherapy
45. Reply to: RE: SUBFOVEAL CHOROIDAL THICKNESS AND VASCULAR ARCHITECTURE IN FELLOW EYES OF PATIENTS WITH CIRCUMSCRIBED CHOROIDAL HEMANGIOMA.
46. A phase Ib study of BGJ398, a pan-FGFR kinase inhibitor in combination with imatinib in patients with advanced gastrointestinal stromal tumor
47. Efficacy of MEK inhibition in patients with histiocytic neoplasms
48. Vitreous Disease and the Technique, Safety and Toxicity of Intravitreal Chemotherapy for Retinoblastoma
49. Marie Curie: Radiation as a Medium That Can Cure
50. Pharmacokinetics of Orbital Topotecan After Ophthalmic Artery Chemosurgery and Intravenous Infusion in the Swine Model
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.